Fig 6. Predicted cumulative whole blood bactericidal activity (WBA) of bedaquiline, rifampin, rifabutin, and the combination of bedaquiline plus rifabutin, based on expected plasma concentrations in vivo during TB treatment, and observed more-than-additive interactions.